Dilution won’t happen at these levels. I think the new S1 will most likely used preferred shares for the purchase. Carnes has said he has financing lined up for the 26 million or so, which he may. It’s not hard to get financing if you have 125+ million in revenues and a positive EPS. Only time will tell, what happens. I think it’s a pretty good bet, we’ll get a run to $1.00 or so on the financials. I think they may sell shares at $2.00 maybe higher. They want to get the most possible for each share or they screw the whole deal up. I don’t think Carnes spent 1.5 years putting this together to have APSI remain an OTC sub $1.00 stock. Carnes does not run the company, but I think he is responsible for getting the K, Q and S-1 out. Of course the S1 will be negotiated with current management and stakeholders.
News 
Market Data 
Discover 
AI
